Free Psychiatry CME

Scientia CME Neuropsychiatry – Psychiatry contains two additional lectures:

• Improving the Treatment and Management of Schizophrenia: An Overview of Current and Novel Approaches (1 hr CME)
• Major Depressive Disorders (MDD): Best Practice And The Role Of Novel Therapies (1 hr CME)

Target Audience: Psychiatrists

Activity Description / Statement of Need:

In this online CME self-learning activity:

Bipolar disorder is a mood disorder characterized by episodes of mania, hypomania, and depression. It affects 3-4% of the U.S. population, represents a substantial societal and economic burden in the United States, is also found to be strongly associated with other major public health concerns like diabetes and cardiovascular disease as well as suicide.

The literature demonstrates that medication nonadherence is a major issue among patients with bipolar disorder. Nonadherence affects approximately 60% of patients and can result in hospitalization, poor effectiveness, increased relapses, and increased risk of morbidity. Other factors, such as patient perceptions, illness severity, and the relationship between the physician and patient, come into play and should be taken into account to optimize adherence.

Target Audience:

Healthcare professionals specializing in: family medicine, internal medicine, mental health, neurology and psychiatry, or those who otherwise commonly care for patients with bipolar or related psychiatric diseases.

In this online CME self-learning program: Alcohol use disorder (AUD), referred to colloquially as alcoholism, is an integration of past terms that have include in past as alcohol dependence or abuse, and may be marked by any one of a number of different symptoms or behaviors that include physical cravings, compulsion, guilt, and frequent consumption over an extended period of time. A quarter of adults report at least one day of heavy drinking over the past year. Alcohol accounts for over 687,000 emergency department visits in the U.S. by people under age 20 per year; worldwide, 76.3 million people are estimated to have AUDs, and they account for an annual mortality rate of 1.8 million. AUD is largely under-recognized and undertreated, constituting one gap in care and justifying continuing HCP education. HCPs are considered well-positioned to be able to recognize AUD, and one of the first missed opportunities to do so is failing to employ a validated screening tool, which might identify a condition well before it reaches the full scale of its adverse psychosocial potential.

Target Audience:

HCPs who are: psychiatrists, primary care physicians, emergency medicine physicians, physician assistants, nurse practitioners, pharmacists, and those who otherwise commonly treat patients suffering from or have a clinical interest in AUD.

By the end of the session the participant will be able to:

• Describe the common clinical presentation(s) of AUD.
• Recall recommended AUD diagnostic criteria, and apply them to a patient case.
• List current treatment options for AUD, including behavioral and pharmacologic therapies and apply them to patient cases using evidence-based medicine.
• Describe challenges to the successful management of AUD relating to treatment adherence.
See full details chevron_right

Individuals with depression, anxiety, bipolar disorder, and other psychiatric conditions first seek help from primary care providers like you. Our courses offer practical guidance on assessing and managing these can’t-miss diagnoses in your patients. Choose from a variety of free psychiatry CME courses to improve care for your patients. Earn credits at no cost today.

Opioid use disorder (OUD) affects millions of individuals globally and is best defined by the Diagnostic and Statistic Manual of Mental Disorders, Fifth Edition (DSM-5) as a condition due to tolerance, manifestation of physical dependence, and loss of control leading to health hazards.The scale of the problem is staggering, and while the causes are manifold, it is fueled in part by widespread availability: the Centers for Disease Control and Prevention estimates that the distribution of prescription opioid analgesics rose over fivefold between 1997 and 2007.

By the end of the session the participant will be able to:

• Describe the epidemiology of OUD and dependence, and outline current and the significance of inappropriate selection and treatment of opioid therapy
• Identify long-acting treatment modalities for OUD and dependence, and apply them to patient cases using evidence-based medicine
• Identify challenges associated with the selection and implementation of drug regimens to the treatment of OUD and dependence, including risk factors for opioid overdose
• Develop strategies for recognizing and improving therapeutic adherence in patients treated for OUD and opioid dependence

Target Audience:

Healthcare professionals specializing in: addiction specialists, pain management specialists, primary care physicians, and psychiatrists; physician assistants, nurse practitioners, nurses, and pharmacists who practice in pain management or substance abuse; and any other health professionals who encounter OUD in the clinical setting.